Oxymetazoline Hydrochloride is the hydrochloride salt form of oxymetazoline, an imidazole derivative with a direct acting sympathomimetic property. Oxymetazoline binds to and activates alpha-2 adrenergic receptors. Upon nasal or ocular administration, oxymetazoline constricts the arterioles in the nose and eye, resulting in decreased nasal and conjunctival congestion, respectively. It is grouped under the following drug class(es): Vasoconstrictors. Its therapeutic use is listed as decongestants and dermatologicals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ocuclear, Afrazine, Nostrilla and Rhofade. Its PubChem CID is 66259.
Oxymetazoline hydrochloride
| CAS No | 2315-02-8 |
|---|---|
| Molecular Formula | C16H25ClN2O |
| Molecular Weight | 296.83 g/mol |
| Synonyms | 6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Oxymetazoline Hydrochloride is the hydrochloride salt form of oxymetazoline, an imidazole derivative with a direct acting sympathomimetic property. Oxymetazoline binds to and activates alpha-2 adrenergic receptors.
The listed CAS number is 2315-02-8.
The listed molecular formula is C16H25ClN2O.
The listed molecular weight is 296.83 g/mol.
6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol;hydrochloride.
The source lists Ocuclear, Afrazine, Nostrilla and Rhofade.